| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.09 | 0.003 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.09 | 0.007 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.081 | 0.008 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |